Wai Chun Bio-Technology Limited (HKG:0660)
0.2600
0.00 (0.00%)
At close: Feb 13, 2026
Wai Chun Bio-Technology Balance Sheet
Financials in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6.56 | 2.16 | 6.31 | 7.52 | 4.64 |
Short-Term Investments | - | - | - | - | 20.66 |
Cash & Short-Term Investments | 6.56 | 2.16 | 6.31 | 7.52 | 25.3 |
Cash Growth | 203.47% | -65.76% | -16.06% | -70.28% | 364.56% |
Accounts Receivable | 28.79 | 29.16 | 37.14 | 48.49 | 19.83 |
Other Receivables | 2.69 | 1.8 | 5.25 | 2.22 | 0.01 |
Receivables | 31.47 | 52.19 | 42.38 | 50.71 | 19.84 |
Inventory | 67.96 | 59.3 | 79.85 | 93.7 | 48.78 |
Prepaid Expenses | - | - | - | 0.1 | - |
Other Current Assets | 0.77 | 0.75 | 0.63 | 0.75 | - |
Total Current Assets | 106.77 | 114.4 | 129.17 | 152.78 | 93.92 |
Property, Plant & Equipment | 93.22 | 80.7 | 111.06 | 97.18 | 92.42 |
Long-Term Deferred Tax Assets | 14.67 | 14.4 | - | - | - |
Total Assets | 214.66 | 209.5 | 240.23 | 249.95 | 186.34 |
Accounts Payable | 76.66 | 99.05 | 63.95 | 44.39 | 39.94 |
Accrued Expenses | 18.06 | 25.36 | 20.55 | 12.74 | 21.02 |
Short-Term Debt | 84.15 | 49.89 | 61.8 | 84.35 | 85.02 |
Current Portion of Long-Term Debt | 11.04 | 73.99 | - | - | 5.51 |
Current Portion of Leases | - | 1.13 | 1.67 | 1.28 | 3.16 |
Current Income Taxes Payable | 1.04 | 1.05 | - | 1.48 | - |
Current Unearned Revenue | 1.29 | 2.32 | 6.7 | 17.29 | 1.79 |
Other Current Liabilities | 85.07 | 1.05 | 4.17 | 16.74 | - |
Total Current Liabilities | 277.31 | 253.85 | 158.83 | 178.27 | 156.43 |
Long-Term Debt | - | 10.89 | 69.73 | 65.65 | 53.69 |
Long-Term Leases | - | - | 1.13 | - | - |
Total Liabilities | 277.31 | 264.74 | 229.69 | 243.92 | 210.12 |
Common Stock | 44.62 | 42.87 | 42.87 | 42.02 | 42.02 |
Additional Paid-In Capital | 210.02 | 209.98 | 209.98 | 209.98 | 209.98 |
Retained Earnings | -353.67 | -347.25 | -342.9 | -369.45 | -375.22 |
Comprehensive Income & Other | 7.96 | 15.15 | 55.05 | 79.72 | 69.64 |
Total Common Equity | -91.08 | -79.25 | -35.01 | -37.73 | -53.58 |
Minority Interest | 28.43 | 24.01 | 45.54 | 43.76 | 29.8 |
Shareholders' Equity | -62.65 | -55.24 | 10.54 | 6.04 | -23.78 |
Total Liabilities & Equity | 214.66 | 209.5 | 240.23 | 249.95 | 186.34 |
Total Debt | 95.19 | 135.9 | 134.34 | 151.28 | 147.37 |
Net Cash (Debt) | -88.63 | -133.74 | -128.02 | -143.76 | -122.07 |
Net Cash Per Share | -0.51 | -0.78 | -0.76 | -0.86 | -0.73 |
Filing Date Shares Outstanding | 178.48 | 171.48 | 171.48 | 168.08 | 168.08 |
Total Common Shares Outstanding | 178.48 | 171.48 | 171.48 | 168.08 | 168.08 |
Working Capital | -170.54 | -139.45 | -29.66 | -25.49 | -62.51 |
Book Value Per Share | -0.51 | -0.46 | -0.20 | -0.22 | -0.32 |
Tangible Book Value | -91.08 | -79.25 | -35.01 | -37.73 | -53.58 |
Tangible Book Value Per Share | -0.51 | -0.46 | -0.20 | -0.22 | -0.32 |
Buildings | 81.87 | 47.42 | 26.74 | 26.66 | - |
Machinery | 91.2 | 84.64 | 71.03 | 69.94 | - |
Construction In Progress | 16.96 | 29.65 | 26.98 | 9.17 | - |
Leasehold Improvements | 2.89 | 2.89 | 2.89 | 2.89 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.